← Leaderboards
Scott Michael Welford
Case Western Reserve University
$5,685,124
Attributed
$5,685,124
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $726.9K · FY2014–25$1M$750K$500K$250K$0
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$5,685,124 · 4
By mechanism
R01$5,242,854 · 2
R21$344,738 · 1
P30$97,532 · 1
Top collaborators
No co-investigators on record.
Most similar at Case Western Reserve University
Same institution · by research overlap
- Raymond F Muzic$5,871,932
- Nora Singer$3,497,199
- Hillard M Lazarus$3,198,402
- Mitchell Machtay$3,887,991
Others in their field
Top investigators on “Cells”
- Lawrence Corey · Fred Hutchinson Cancer Center$536,344,731
- Barton F Haynes · Duke University$457,457,619
- David Heimbrook · Leidos Biomedical Research, Inc.$454,789,509
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$299,104,942
- Dennis R. Burton · Scripps Research Institute$278,781,854
- Mary M Horowitz · Medical College Of Wisconsin$237,383,608
Research focus
CellsRadiation TherapyTumorStandard Of CareLinkPatient-Focused OutcomesNovel TherapeuticsRegulationSignal TransductionMediatingNeoplastic CellTumor GrowthCessation Of LifeMalignant NeoplasmsModalityRadiationPathway InteractionsIonizing RadiationToxic EffectImmunocompetentClustered Regularly Interspaced Short Palindromic RepeatsLesionAutocrineCell Death
Grant awards (20)
Adipokine Signaling as a Therapeutically Targetable Driver of Tumor Metabolism$350,394
R01 · FY2025 · CA · contact PI
Polyamine and Glutamate Driven Interactions in the Glioblastoma-Brain Microenvironment$347,621
R01 · FY2025 · CA · contact PI
Adipokine Signaling as a Therapeutically Targetable Driver of Tumor Metabolism$341,057
R01 · FY2024 · CA · contact PI
Polyamine and Glutamate Driven Interactions in the Glioblastoma-Brain Microenvironment$330,239
R01 · FY2024 · CA · contact PI
Adipokine Signaling as a Therapeutically Targetable Driver of Tumor Metabolism$353,025
R01 · FY2023 · CA · contact PI
Polyamine and Glutamate Driven Interactions in the Glioblastoma-Brain Microenvironment$340,669
R01 · FY2023 · CA · contact PI
Adipokine Signaling as a Therapeutically Targetable Driver of Tumor Metabolism$365,248
R01 · FY2022 · CA · contact PI
Polyamine and Glutamate Driven Interactions in the Glioblastoma-Brain Microenvironment$340,669
R01 · FY2022 · CA · contact PI
Adipokine Signaling as a Therapeutically Targetable Driver of Tumor Metabolism$379,312
R01 · FY2021 · CA · contact PI
Polyamine and Glutamate Driven Interactions in the Glioblastoma-Brain Microenvironment$347,621
R01 · FY2021 · CA · contact PI
Polyamine Catabolism and Therapeutic Resistance in Glioblastoma Multiforme$329,567
R01 · FY2019 · CA · contact PI
Radiation Resources Shared Resource$43,565
P30 · FY2019 · CA · contact PI
Polyamine Catabolism and Therapeutic Resistance in Glioblastoma Multiforme$342,596
R01 · FY2018 · CA · contact PI
Radiation Resources Shared Resource$44,709
P30 · FY2018 · CA · contact PI
Radiation Resources Shared Resource$9,258
P30 · FY2018 · CA · contact PI
Polyamine Catabolism and Therapeutic Resistance in Glioblastoma Multiforme$351,131
R01 · FY2017 · CA · contact PI
Polyamine Catabolism and Therapeutic Resistance in Glioblastoma Multiforme$361,136
R01 · FY2016 · CA · contact PI
Polyamine Catabolism and Therapeutic Resistance in Glioblastoma Multiforme$362,569
R01 · FY2015 · CA · contact PI
A novel soluble receptor-based therapy for Kidney Cancer$172,369
R21 · FY2015 · CA · contact PI
A novel soluble receptor-based therapy for Kidney Cancer$172,369
R21 · FY2014 · CA · contact PI